CME Group Inc.
DE ˙ XTRA ˙ US12572Q1058
217,80 € ↑3,15 (1,47%)
2026-06-03
AKTIENPREIS
SecurityDE:MX4A / CME Group Inc.
InstitutionRathbone Brothers plc
Latest Disclosed Ownership990,360 shares
Latest Disclosed Value $ 292,502,826
Rathbone Brothers plc reports 0.92% decrease in ownership of MX4A / CME Group Inc.

On May 12, 2026 - Rathbone Brothers plc filed a 13F-HR form disclosing ownership of 990,360 shares of CME Group Inc. (DE:MX4A) valued at $252,987,462 USD as of March 31, 2026. The entity filed a previous 13F-HR/A on February 6, 2026 disclosing 999,530 shares of CME Group Inc.. This represents a change in shares of -0.92% during the quarter. The current value of the position is $215,700,408 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-12 2026-03-31 13F CME GROUP INC USD0.01 Cls A COM 12572Q105 990,360 -9,170 -0.92 292,503 7.16 1.2497
2026-02-06 2025-12-31 13F/A-1 CME GROUP INC USD0.01 Cls A COM 12572Q105 999,530 10,602 1.07 272,952 2.15 1.0805
2026-01-21 2025-12-31 13F CME GROUP INC USD0.01 Cls A COM 12572Q105 999,530 10,602 272,952 1.0805
2025-11-13 2025-09-30 13F CME GROUP INC USD0.01 Cls A COM 12572Q105 988,928 51,570 5.50 267,198 3.42 1.0849
2025-08-07 2025-06-30 13F CME GROUP INC USD0.01 Cls A COM 12572Q105 937,358 118 0.01 258,355 3.91 1.1143
2025-05-13 2025-03-31 13F CME GROUP INC USD0.01 Cls A COM 12572Q105 937,240 -10,092 -1.07 248,640 13.02 1.2015
2025-02-13 2024-12-31 13F CME GROUP INC USD0.01 Cls A COM 12572Q105 947,332 -368,452 -28.00 219,999 -24.22 1.0650
2024-11-13 2024-09-30 13F CME GROUP INC USD0.01 Cls A COM 12572Q105 1,315,784 4,310 0.33 290,328 12.60 1.4650
2024-08-09 2024-06-30 13F CME GROUP INC USD0.01 Cls A COM 12572Q105 1,311,474 46,276 3.66 257,836 -5.34 1.4043
2024-05-14 2024-03-31 13F CME GROUP INC USD0.01 Cls A COM 12572Q105 1,265,198 216,709 20.67 272,384 23.36 1.5719
2024-02-13 2023-12-31 13F CME GROUP INC USD0.01 Cls A COM 12572Q105 1,048,489 55,433 5.58 220,812 11.06 1.4230
2023-11-13 2023-09-30 13F CME GROUP INC USD0.01 Cls A COM 12572Q105 993,056 19,289 1.98 198,830 10.20 1.4419
2023-08-04 2023-06-30 13F CME GROUP INC USD0.01 Cls A COM 12572Q105 973,767 28,821 3.05 180,429 -0.30 1.6838
2023-05-12 2023-03-31 13F CME GROUP INC USD0.01 Cls A COM 12572Q105 944,946 -21,967 -2.27 180,976 11.30 1.8504
2023-02-14 2022-12-31 13F CME GROUP INC USD0.01 Cls A COM 12572Q105 966,913 22,741 2.41 162,596 -2.78 1.8308
2022-11-14 2022-09-30 13F/A-1 CME GROUP INC USD0.01 Cls A COM 12572Q105 944,172 2,381 0.25 167,241 -13.25 2.0634
2022-11-03 2022-09-30 13F CME GROUP INC USD0.01 Cls A COM 12572Q105 944,172 2,381 167,241 2.0634
2022-08-12 2022-06-30 13F CME GROUP INC USD0.01 Cls A COM 12572Q105 941,791 44,337 4.94 192,785 -9.69 2.2099
2022-05-11 2022-03-31 13F CME GROUP INC USD0.01 Cls A COM 12572Q105 897,454 40,750 4.76 213,468 9.07 2.1780
2022-02-10 2021-12-31 13F CME GROUP INC USD0.01 Cls A COM 12572Q105 856,704 434,699 103.01 195,723 139.84 1.9021
2021-11-04 2021-09-30 13F CME GROUP INC USD0.01 Cls A COM 12572Q105 422,005 58,486 16.09 81,607 5.55 0.8780
2021-07-30 2021-06-30 13F CME GROUP INC USD0.01 Cls A COM 12572Q105 363,519 65,550 22.00 77,313 27.05 0.8589
2021-05-14 2021-03-31 13F CME GROUP INC USD0.01 Cls A COM 12572Q105 297,969 95,528 47.19 60,854 65.12 0.7792
2021-02-11 2020-12-31 13F CME GROUP INC USD0.01 Cls A COM 12572Q105 202,441 29,198 16.85 36,854 27.15 0.5233
2020-11-13 2020-09-30 13F CME GROUP INC USD0.01 Cls A COM 12572Q105 173,243 77,727 81.38 28,985 86.70 0.4960
2020-08-07 2020-06-30 13F CME GROUP INC USD0.01 Cls A COM 12572Q105 95,516 29,325 44.30 15,525 35.65 0.3152
2020-05-04 2020-03-31 13F CME GROUP INC USD0.01 Cls A COM 12572Q105 66,191 22,666 52.08 11,445 31.01 0.3333
2020-02-11 2019-12-31 13F CME GROUP INC USD0.01 Cls A COM 12572Q105 43,525 -124,695 -74.13 8,736 -75.43 0.2300
2019-11-13 2019-09-30 13F CME GROUP INC USD0.01 Cls A COM 12572Q105 168,220 15,484 10.14 35,552 19.91 1.0097
2019-08-12 2019-06-30 13F CME GROUP INC USD0.01 Cls A COM 12572Q105 152,736 -108 -0.07 29,648 17.86 0.9282
2019-05-09 2019-03-31 13F CME GROUP INC USD0.01 Cls A COM 12572Q105 152,844 148,674 3,565.32 25,155 3,108.55 0.8271
2019-02-12 2018-12-31 13F CME GROUP INC USD0.01 Cls A COM 12572Q105 4,170 4,170 784 0.0300
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.